SPAC Feed

XRPPower verfolgt die Entwicklungsphilosophie von Sicherheit, Transparenz, Offenheit und Nachvollziehbarkeit. Die Produktregeln sind klar und eindeutig, ohne versteckte Gebühren oder implizite Bedingungen, und die täglichen Erträge sind nicht von Marktschwankungen abhängig.

XRPPower verfolgt die Entwicklungsphilosophie von Sicherheit, Transparenz, Offenheit und Nachvollziehbarkeit. Die Produktregeln sind klar und eindeutig, ohne versteckte Gebühren oder implizite Bedingungen, und die täglichen Erträge sind nicht von Marktschwankungen abhängig.

XRPPower s’appuie sur des principes de sécurité, de transparence, d’ouverture et de traçabilité. Les règles de ses produits sont claires et accessibles, sans frais cachés ni conditions implicites. Les rendements quotidiens sont déterminés conformément aux règles des produits de la plateforme.

XRPPower s'appuie sur des principes de sécurité, de transparence, d'ouverture et de traçabilité. Les règles de ses produits sont claires et accessibles, sans frais cachés ni conditions implicites. Les rendements quotidiens sont déterminés conformément aux règles des produits de la plateforme.

Dubai, United Arab Emirates

Paterson, NJ, July 10, 2026 (GLOBE NEWSWIRE) — A team of eighth-grade students from Martin Luther King Jr. School, PS #30, created the top public service announcement addressing the dangers of substance misuse to win the Partnership for a Drug-Free New Jersey’s (PDFNJ) annual statewide Middle School PSA Challenge.

 
Friday, July 10, 2026

Air Quality Monitoring market is expected to register a CAGR of 7.02% from 2026 to 2034, with the market size expanding from US$ 6.55 Billion

Shares Now Available on the Frankfurt Stock Exchange Under Ticker Symbol “2I1”

Shares Now Available on the Frankfurt Stock Exchange Under Ticker Symbol "2I1"

Proposed cooperation is expected to support Jiuzi’s AI intelligent imaging and data platform commercialization strategy

Partnership to focus on joint sales and marketing pursuits across critical infrastructure markets while maintaining strategic dialogue as Actelis seeks Nasdaq relisting

Partnership to focus on joint sales and marketing pursuits across critical infrastructure markets while maintaining strategic dialogue as Actelis seeks Nasdaq relisting

Management to participate in investor meetings on July 14-15 in Boston

Beamr partners with Intempora, a dSPACE company, bringing its compression to the RTMaps middleware – the autonomous-driving development platform used by OEMs and Tier 1 suppliers worldwide

Advancing field-ready solutions in close partnership with Tier-1 defense innovators worldwide

Acquisition of a 60% stake in Project35 adds a field-proven portfolio of unmanned aerial systems, autonomous interceptor, and a full counter-UAV suite, backed by an experienced Israeli engineering team and Tier-1 defense customer relationships

Acquisition of a 60% stake in Project35 adds a field-proven portfolio of unmanned aerial systems, autonomous interceptor, and a full counter-UAV suite, backed by an experienced Israeli engineering team and Tier-1 defense customer relationships

The U.S. Chronic Obstructive Pulmonary Disease Market is projected to grow from USD 6.93 Billion in 2025 to USD 10.93 Billion by 2035, while Europe is expected to expand from USD 7.02 Billion to USD 10.98 Billion, supported by increasing COPD diagnosis, combination therapies, biologics, and digital respiratory care adoption.

The U.S. Chronic Obstructive Pulmonary Disease Market is projected to grow from USD 6.93 Billion in 2025 to USD 10.93 Billion by 2035, while Europe is expected to expand from USD 7.02 Billion to USD 10.98 Billion, supported by increasing COPD diagnosis, combination therapies, biologics, and digital respiratory care adoption.

Vancouver, Canada, July 10, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a biotech company developing novel, non-hallucinogenic, next-generation, neuroplastogen-derived therapeutics to solve major under-treated mental health problems, with a focus on Alcohol Use Disorder and other addiction related diagnoses, today announced that it has submitted a formal response to the U.S. Department of Health and Human Services (HHS) Request for Information (RFI) about MEAI’s potential as an innovative, empirically-evidenced intervention for the treatment of addiction.

NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) — via NetworkNewsWire (“NNW”) — Wrap Technologies Inc. (NASDAQ: WRAP) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.

The U.S. Orthopedic Imaging Equipment Market is projected to grow from USD 1.48 Billion in 2025 to USD 2.36 Billion by 2035, while Europe is expected to expand from USD 1.38 Billion to USD 2.18 Billion, supported by AI-powered imaging adoption and growing demand for precision orthopedic diagnostics.

The U.S. Orthopedic Imaging Equipment Market is projected to grow from USD 1.48 Billion in 2025 to USD 2.36 Billion by 2035, while Europe is expected to expand from USD 1.38 Billion to USD 2.18 Billion, supported by AI-powered imaging adoption and growing demand for precision orthopedic diagnostics.